Our qRT-PCR and IHC experiments provided initial biological validation, confirming dysregulation of key model genes (e.g., CHMP2A, CHMP4B, TREM2) in HCC cells and tissues. The gene discussed is CHMP4B; the disease is hepatocellular carcinoma.